# Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen

> **NCT03934450** · PHASE1 · COMPLETED · sponsor: **University of Mississippi, Oxford** · enrollment: 36 (actual)

## Conditions studied

- Malaria
- Glucose 6 Phosphate Dehydrogenase Deficiency

## Interventions

- **DRUG:** RPQ
- **DRUG:** SPQ
- **DRUG:** Primaquine Phosphate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03934450
- **Lead sponsor:** University of Mississippi, Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-17
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03934450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03934450, "Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03934450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*